| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CYC1 LRRC55 CNNM4 SLC9A8 SLC16A13 SLC9A3 SLC12A9 RHBG SLC35B4 SLC22A23 PGRMC2 PKD1L1 GHITM TMEM175 SLC17A4 SLC37A2 ABCC12 SLC49A3 AQP8 GRIN2C SLC34A3 ASIC4 APOL2 SLC29A2 SLC9C2 SLC2A2 SLC16A8 SLC22A31 | 4.17e-16 | 1180 | 74 | 28 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CYC1 LRRC55 CNNM4 SLC9A8 SLC16A13 SLC9A3 SLC12A9 RHBG SLC35B4 SLC22A23 PGRMC2 PKD1L1 GHITM TMEM175 SLC17A4 SLC37A2 ABCC12 SLC49A3 AQP8 GRIN2C SLC34A3 ASIC4 APOL2 SLC29A2 SLC9C2 PLTP SLC2A2 SLC16A8 SLC22A31 | 4.20e-16 | 1289 | 74 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 RHBG PKD1L1 GHITM TMEM175 SLC17A4 SLC37A2 AQP8 GRIN2C SLC34A3 ASIC4 APOL2 SLC9C2 | 2.17e-10 | 758 | 74 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 RHBG PKD1L1 GHITM TMEM175 SLC17A4 AQP8 GRIN2C SLC34A3 ASIC4 SLC9C2 | 9.17e-10 | 627 | 74 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 SLC9C2 | 1.44e-08 | 465 | 74 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 SLC9C2 | 1.27e-07 | 664 | 74 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC9A8 SLC16A13 SLC9A3 SLC12A9 GHITM SLC17A4 SLC37A2 SLC34A3 SLC9C2 SLC16A8 | 1.37e-07 | 296 | 74 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | CYC1 SLC9A8 SLC16A13 SLC9A3 SLC12A9 GHITM SLC17A4 SLC37A2 ABCC12 SLC34A3 SLC9C2 SLC16A8 | 1.72e-07 | 477 | 74 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 APOL2 SLC9C2 | 1.73e-07 | 793 | 74 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 2.86e-06 | 27 | 74 | 4 | GO:0023026 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 2.86e-06 | 27 | 74 | 4 | GO:0051139 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.32e-06 | 171 | 74 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 7.89e-06 | 11 | 74 | 3 | GO:0032395 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.55e-05 | 301 | 74 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 1.59e-05 | 41 | 74 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 1.73e-05 | 14 | 74 | 3 | GO:0015386 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.92e-05 | 43 | 74 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 2.64e-05 | 16 | 74 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 3.25e-05 | 49 | 74 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.62e-05 | 167 | 74 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.54e-05 | 19 | 74 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 7.00e-05 | 188 | 74 | 6 | GO:0015078 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 9.35e-05 | 24 | 74 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.61e-04 | 138 | 74 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | symporter activity | 2.38e-04 | 150 | 74 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.34e-04 | 171 | 74 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | channel activity | 7.12e-04 | 525 | 74 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.21e-04 | 526 | 74 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | CD4 receptor binding | 7.29e-04 | 11 | 74 | 2 | GO:0042609 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.61e-04 | 293 | 74 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 8.73e-04 | 12 | 74 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 8.73e-04 | 12 | 74 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.37e-03 | 59 | 74 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | high-density lipoprotein particle binding | 1.38e-03 | 15 | 74 | 2 | GO:0008035 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.47e-03 | 20 | 74 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | heme binding | 2.58e-03 | 154 | 74 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 3.23e-03 | 164 | 74 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | immune receptor activity | 3.30e-03 | 165 | 74 | 4 | GO:0140375 | |
| GeneOntologyMolecularFunction | antigen binding | 5.44e-03 | 190 | 74 | 4 | GO:0003823 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 5.88e-03 | 31 | 74 | 2 | GO:0030247 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 7.09e-03 | 459 | 74 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 7.45e-03 | 35 | 74 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 7.45e-03 | 35 | 74 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.90e-03 | 343 | 74 | 5 | GO:0005261 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 RHBG PKD1L1 GHITM TMEM175 SLC17A4 SLC37A2 AQP8 GRIN2C SLC34A3 ASIC4 SLC9C2 | 8.46e-08 | 1017 | 74 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 RHBG PKD1L1 GHITM TMEM175 SLC17A4 AQP8 GRIN2C SLC34A3 ASIC4 SLC9C2 | 1.31e-07 | 922 | 74 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 2.69e-07 | 16 | 74 | 4 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 2.69e-07 | 16 | 74 | 4 | GO:0002503 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 8.72e-07 | 21 | 74 | 4 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 8.72e-07 | 21 | 74 | 4 | GO:0002501 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 SLC22A23 PGRMC2 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 SLC9C2 CLDN10 SLC22A31 | 1.21e-06 | 1374 | 74 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.09e-06 | 32 | 74 | 4 | GO:0019886 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 SLC9C2 | 5.51e-06 | 942 | 74 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 8.24e-06 | 36 | 74 | 4 | GO:0002495 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.74e-06 | 208 | 74 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.03e-05 | 38 | 74 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | metal ion transport | LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 PGRMC2 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 SLC9C2 | 1.09e-05 | 1000 | 74 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 PGRMC2 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 SLC9C2 | 1.25e-05 | 1157 | 74 | 15 | GO:0006812 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC16A13 SLC35B4 SLC17A4 SLC37A2 PNPLA8 AQP8 NMB G6PC1 SLC2A2 SLC16A8 | 1.48e-05 | 515 | 74 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.97e-05 | 232 | 74 | 7 | GO:0071805 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 2.46e-05 | 96 | 74 | 5 | GO:1901264 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 2.64e-05 | 48 | 74 | 4 | GO:0002478 | |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 3.34e-05 | 170 | 74 | 6 | GO:1902600 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CYC1 LRRC55 CNNM4 SLC9A8 SLC9A3 SLC12A9 PKD1L1 GHITM TMEM175 SLC17A4 GRIN2C SLC34A3 ASIC4 SLC9C2 | 3.64e-05 | 1115 | 74 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | myeloid dendritic cell antigen processing and presentation | 3.80e-05 | 3 | 74 | 2 | GO:0002469 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 5.44e-05 | 272 | 74 | 7 | GO:0006813 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 5.59e-05 | 58 | 74 | 4 | GO:0019884 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 5.83e-05 | 275 | 74 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.61e-04 | 76 | 74 | 4 | GO:0048002 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 1.85e-04 | 31 | 74 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immune response to tumor cell | 2.64e-04 | 7 | 74 | 2 | GO:0002842 | |
| GeneOntologyBiologicalProcess | hexose phosphate transport | 2.64e-04 | 7 | 74 | 2 | GO:0015712 | |
| GeneOntologyBiologicalProcess | glucose-6-phosphate transport | 2.64e-04 | 7 | 74 | 2 | GO:0015760 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 3.65e-04 | 94 | 74 | 4 | GO:0051453 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CNNM4 SLC9A8 SLC9A3 SLC12A9 RHBG HLA-DRB1 GHITM TMEM175 PNPLA8 SLC34A3 SLC9C2 G6PC1 SLC2A2 | 4.56e-04 | 1249 | 74 | 13 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 4.79e-04 | 101 | 74 | 4 | GO:0030641 | |
| GeneOntologyBiologicalProcess | regulation of pH | 9.16e-04 | 120 | 74 | 4 | GO:0006885 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 9.65e-04 | 13 | 74 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | sodium-dependent phosphate transport | 9.65e-04 | 13 | 74 | 2 | GO:0044341 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 1.01e-03 | 213 | 74 | 5 | GO:0015718 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immune response to tumor cell | 1.12e-03 | 14 | 74 | 2 | GO:0002840 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 3.32e-07 | 17 | 74 | 4 | GO:0042613 | |
| GeneOntologyCellularComponent | MHC protein complex | 2.04e-06 | 26 | 74 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 6.97e-06 | 35 | 74 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RETREG2 TEX2 ZDHHC6 SLC35B4 HLA-DRB1 HLA-DRB3 HLA-DRB4 DERL3 HLA-DRB5 SLC37A2 PNPLA8 ABCC12 AQP8 GRIN2C APOL2 G6PC1 | 9.28e-06 | 1293 | 74 | 16 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RETREG2 TEX2 ZDHHC6 SLC35B4 HLA-DRB1 HLA-DRB3 HLA-DRB4 DERL3 HLA-DRB5 SLC37A2 PNPLA8 ABCC12 AQP8 GRIN2C APOL2 G6PC1 | 9.83e-06 | 1299 | 74 | 16 | GO:0098827 |
| GeneOntologyCellularComponent | brush border membrane | 1.14e-05 | 83 | 74 | 5 | GO:0031526 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RETREG2 TEX2 ZDHHC6 SLC35B4 HLA-DRB1 HLA-DRB3 HLA-DRB4 DERL3 HLA-DRB5 SLC37A2 PNPLA8 ABCC12 AQP8 GRIN2C APOL2 G6PC1 | 1.28e-05 | 1327 | 74 | 16 | GO:0042175 |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.50e-05 | 48 | 74 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 4.84e-05 | 112 | 74 | 5 | GO:0032588 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC9A8 SLC9A3 CLDN24 SLC17A4 AQP8 SLC34A3 SLC29A2 SLC2A2 SLC16A8 | 5.42e-05 | 487 | 74 | 9 | GO:0016324 |
| GeneOntologyCellularComponent | autolysosome membrane | 7.38e-05 | 4 | 74 | 2 | GO:0120281 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 7.83e-05 | 64 | 74 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.38e-04 | 320 | 74 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.78e-04 | 79 | 74 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | brush border | 2.05e-04 | 152 | 74 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | apical part of cell | SLC9A8 SLC9A3 CLDN24 SLC17A4 AQP8 SLC34A3 SLC29A2 SLC2A2 SLC16A8 | 2.37e-04 | 592 | 74 | 9 | GO:0045177 |
| GeneOntologyCellularComponent | basal plasma membrane | 2.56e-04 | 354 | 74 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 3.80e-04 | 378 | 74 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | late endosome membrane | 4.35e-04 | 179 | 74 | 5 | GO:0031902 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 4.56e-04 | 101 | 74 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.29e-04 | 110 | 74 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | immunological synapse | 6.98e-04 | 49 | 74 | 3 | GO:0001772 | |
| GeneOntologyCellularComponent | Golgi membrane | SLC9A8 SLC16A13 SLC35B4 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 NDST2 PDGFC | 9.80e-04 | 721 | 74 | 9 | GO:0000139 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.17e-03 | 223 | 74 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | autolysosome | 1.82e-03 | 18 | 74 | 2 | GO:0044754 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.84e-03 | 147 | 74 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | secondary lysosome | 3.80e-03 | 26 | 74 | 2 | GO:0005767 | |
| GeneOntologyCellularComponent | cell projection membrane | 4.22e-03 | 431 | 74 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | trans-Golgi network | 4.60e-03 | 306 | 74 | 5 | GO:0005802 | |
| GeneOntologyCellularComponent | endosome membrane | 5.39e-03 | 602 | 74 | 7 | GO:0010008 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 6.80e-03 | 212 | 74 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | high-density lipoprotein particle | 6.82e-03 | 35 | 74 | 2 | GO:0034364 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 7.14e-03 | 215 | 74 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | late endosome | 7.84e-03 | 348 | 74 | 5 | GO:0005770 | |
| HumanPheno | Nephrolithiasis | 6.45e-06 | 144 | 18 | 6 | HP:0000787 | |
| HumanPheno | Abnormal urinary electrolyte concentration | 5.66e-05 | 126 | 18 | 5 | HP:0012591 | |
| HumanPheno | Doll-like facies | 7.05e-05 | 4 | 18 | 2 | HP:0000295 | |
| HumanPheno | Abnormal urine cation concentration | 1.13e-04 | 75 | 18 | 4 | HP:0011865 | |
| HumanPheno | Abnormality of urine calcium concentration | 1.13e-04 | 75 | 18 | 4 | HP:0011280 | |
| Domain | MFS_dom | SLC16A13 SLC22A23 SLC17A4 SLC37A2 MFSD6L SLC49A3 SLC29A2 SLC2A2 SLC16A8 SLC22A31 | 1.09e-10 | 134 | 73 | 10 | IPR020846 |
| Domain | MFS | SLC16A13 SLC22A23 SLC17A4 SLC37A2 MFSD6L SLC49A3 SLC2A2 SLC16A8 SLC22A31 | 3.68e-10 | 108 | 73 | 9 | PS50850 |
| Domain | MHC_II_b_N | 1.49e-08 | 8 | 73 | 4 | PD000328 | |
| Domain | MHC_II_beta | 2.67e-08 | 9 | 73 | 4 | PF00969 | |
| Domain | MHC_II_b_N | 2.67e-08 | 9 | 73 | 4 | IPR000353 | |
| Domain | MHC_II_beta | 2.67e-08 | 9 | 73 | 4 | SM00921 | |
| Domain | MHC_II_a/b_N | 2.09e-07 | 14 | 73 | 4 | IPR014745 | |
| Domain | - | 2.09e-07 | 14 | 73 | 4 | 3.10.320.10 | |
| Domain | Cation/H_exchanger_CPA1 | 9.24e-06 | 11 | 73 | 3 | IPR018422 | |
| Domain | MFS_1 | 1.26e-05 | 77 | 73 | 5 | PF07690 | |
| Domain | MFS | 1.26e-05 | 77 | 73 | 5 | IPR011701 | |
| Domain | MHC_I/II-like_Ag-recog | 1.43e-05 | 38 | 73 | 4 | IPR011162 | |
| Domain | Na_H_Exchanger | 2.02e-05 | 14 | 73 | 3 | PF00999 | |
| Domain | Cation/H_exchanger | 2.02e-05 | 14 | 73 | 3 | IPR006153 | |
| Domain | C1-set | 5.86e-05 | 54 | 73 | 4 | PF07654 | |
| Domain | IGc1 | 6.76e-05 | 56 | 73 | 4 | SM00407 | |
| Domain | Ig_C1-set | 7.77e-05 | 58 | 73 | 4 | IPR003597 | |
| Domain | Ig/MHC_CS | 7.77e-05 | 58 | 73 | 4 | IPR003006 | |
| Domain | Claudin_CS | 8.36e-05 | 22 | 73 | 3 | IPR017974 | |
| Domain | CLAUDIN | 8.36e-05 | 22 | 73 | 3 | PS01346 | |
| Domain | IG_MHC | 8.88e-05 | 60 | 73 | 4 | PS00290 | |
| Domain | Claudin | 1.75e-04 | 28 | 73 | 3 | IPR006187 | |
| Domain | MFS_sugar_transport-like | 3.73e-04 | 36 | 73 | 3 | IPR005828 | |
| Domain | Sugar_tr | 3.73e-04 | 36 | 73 | 3 | PF00083 | |
| Domain | PMP22_Claudin | 5.10e-04 | 40 | 73 | 3 | PF00822 | |
| Domain | NaH_exchanger | 5.33e-04 | 9 | 73 | 2 | IPR004709 | |
| Domain | PMP22/EMP/MP20/Claudin | 7.23e-04 | 45 | 73 | 3 | IPR004031 | |
| Domain | Tetraspanin_CS | 3.02e-03 | 21 | 73 | 2 | IPR018503 | |
| Domain | SUGAR_TRANSPORT_1 | 3.93e-03 | 24 | 73 | 2 | PS00216 | |
| Domain | TM4_1 | 4.61e-03 | 26 | 73 | 2 | PS00421 | |
| Domain | Sugar_transporter_CS | 6.93e-03 | 32 | 73 | 2 | IPR005829 | |
| Domain | Tetraspanin | 6.93e-03 | 32 | 73 | 2 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 6.93e-03 | 32 | 73 | 2 | IPR008952 | |
| Domain | Tetraspannin | 7.36e-03 | 33 | 73 | 2 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 7.36e-03 | 33 | 73 | 2 | IPR018499 | |
| Domain | cNMP | 7.80e-03 | 34 | 73 | 2 | SM00100 | |
| Domain | cNMP-bd_dom | 8.25e-03 | 35 | 73 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 8.25e-03 | 35 | 73 | 2 | PS50042 | |
| Domain | ANF_lig-bd_rcpt | 9.19e-03 | 37 | 73 | 2 | IPR001828 | |
| Domain | ANF_receptor | 9.19e-03 | 37 | 73 | 2 | PF01094 | |
| Domain | cNMP-bd-like | 9.67e-03 | 38 | 73 | 2 | IPR018490 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.61e-09 | 14 | 56 | 5 | M1473 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 4.84e-08 | 87 | 56 | 7 | M6856 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 7.22e-08 | 11 | 56 | 4 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 7.22e-08 | 11 | 56 | 4 | M22048 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 1.55e-07 | 13 | 56 | 4 | M18928 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 2.17e-07 | 14 | 56 | 4 | M22023 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 2.17e-07 | 14 | 56 | 4 | M10765 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 2.95e-07 | 15 | 56 | 4 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 2.95e-07 | 15 | 56 | 4 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 2.95e-07 | 15 | 56 | 4 | M7298 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A8 SLC9A3 RHBG SLC35B4 DERL3 AQP8 SLC34A3 ASIC4 SLC29A2 SLC9C2 PLTP ADCY7 SLC2A2 SLC16A8 | 7.41e-07 | 736 | 56 | 14 | M27287 |
| Pathway | BIOCARTA_CSK_PATHWAY | 1.55e-06 | 22 | 56 | 4 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 1.55e-06 | 22 | 56 | 4 | M1467 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.86e-06 | 52 | 56 | 5 | M13103 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 1.87e-06 | 23 | 56 | 4 | M6705 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.14e-06 | 238 | 56 | 8 | MM15076 | |
| Pathway | REACTOME_PD_1_SIGNALING | 4.26e-06 | 28 | 56 | 4 | M18810 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 4.93e-06 | 29 | 56 | 4 | M6910 | |
| Pathway | KEGG_ASTHMA | 5.67e-06 | 30 | 56 | 4 | M13950 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.78e-06 | 249 | 56 | 8 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A8 SLC9A3 RHBG SLC35B4 DERL3 AQP8 SLC34A3 ASIC4 SLC29A2 PLTP SLC2A2 SLC16A8 | 1.15e-05 | 681 | 56 | 12 | MM14985 |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.34e-05 | 37 | 56 | 4 | M18615 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.39e-05 | 133 | 56 | 6 | M16476 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.66e-05 | 39 | 56 | 4 | M16523 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 2.03e-05 | 41 | 56 | 4 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.46e-05 | 43 | 56 | 4 | M12617 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 3.82e-05 | 48 | 56 | 4 | M615 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 4.23e-05 | 98 | 56 | 5 | M965 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.69e-04 | 70 | 56 | 4 | M12294 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 1.88e-04 | 72 | 56 | 4 | M3126 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 2.09e-04 | 74 | 56 | 4 | M17386 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 4.07e-04 | 88 | 56 | 4 | M16004 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY | 4.19e-04 | 37 | 56 | 3 | M47769 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 5.48e-04 | 9 | 56 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 5.48e-04 | 9 | 56 | 2 | MM15079 | |
| Pathway | WP_DISORDERS_OF_FRUCTOSE_METABOLISM | 1.37e-03 | 14 | 56 | 2 | M45540 | |
| Pathway | REACTOME_TCR_SIGNALING | 1.47e-03 | 124 | 56 | 4 | M15381 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 1.49e-03 | 57 | 56 | 3 | M39812 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.56e-03 | 126 | 56 | 4 | M705 | |
| Pathway | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | 1.79e-03 | 16 | 56 | 2 | MM14808 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 2.24e-03 | 139 | 56 | 4 | M4741 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | 2.54e-03 | 19 | 56 | 2 | MM14807 | |
| Pathway | REACTOME_PD_1_SIGNALING | 2.81e-03 | 20 | 56 | 2 | MM15001 | |
| Pathway | WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX | 3.10e-03 | 21 | 56 | 2 | M39876 | |
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 1.89e-11 | 4 | 74 | 4 | 3476943 | |
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 26740600 | ||
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 1.89e-11 | 4 | 74 | 4 | 12144077 | |
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 18520346 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 11782380 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 17910142 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 9.42e-11 | 5 | 74 | 4 | 1970352 | |
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 7645219 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 12392858 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 12209103 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 23152536 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 17411376 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 9.42e-11 | 5 | 74 | 4 | 17507489 | |
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 7734415 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 9.42e-11 | 5 | 74 | 4 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 9.42e-11 | 5 | 74 | 4 | 12144632 | |
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 9.42e-11 | 5 | 74 | 4 | 17182961 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 9.42e-11 | 5 | 74 | 4 | 12202216 | |
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 11082517 | ||
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 15896200 | ||
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 17153701 | ||
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 18305173 | ||
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 15902698 | ||
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 11997714 | ||
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 2.82e-10 | 6 | 74 | 4 | 19235017 | |
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 2.82e-10 | 6 | 74 | 4 | 14508706 | |
| Pubmed | 6.58e-10 | 7 | 74 | 4 | 18569076 | ||
| Pubmed | 6.58e-10 | 7 | 74 | 4 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 6.58e-10 | 7 | 74 | 4 | 12230470 | |
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 6.58e-10 | 7 | 74 | 4 | 18846964 | |
| Pubmed | 6.58e-10 | 7 | 74 | 4 | 20307907 | ||
| Pubmed | 1.31e-09 | 8 | 74 | 4 | 17106278 | ||
| Pubmed | 1.31e-09 | 8 | 74 | 4 | 19223392 | ||
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 1.31e-09 | 8 | 74 | 4 | 16405603 | |
| Pubmed | 1.31e-09 | 8 | 74 | 4 | 12296785 | ||
| Pubmed | 1.31e-09 | 8 | 74 | 4 | 23729440 | ||
| Pubmed | 2.36e-09 | 9 | 74 | 4 | 23170932 | ||
| Pubmed | 2.36e-09 | 9 | 74 | 4 | 24505475 | ||
| Pubmed | 3.93e-09 | 10 | 74 | 4 | 15784911 | ||
| Pubmed | 3.93e-09 | 10 | 74 | 4 | 12956878 | ||
| Pubmed | 3.93e-09 | 10 | 74 | 4 | 8450224 | ||
| Pubmed | 6.16e-09 | 11 | 74 | 4 | 21085635 | ||
| Pubmed | 6.16e-09 | 11 | 74 | 4 | 22808111 | ||
| Pubmed | Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. | 9.25e-09 | 3 | 74 | 3 | 12358860 | |
| Pubmed | Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution. | 9.25e-09 | 3 | 74 | 3 | 8462990 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 3466180 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 1428007 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 20371654 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 7652736 | ||
| Pubmed | Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. | 9.25e-09 | 3 | 74 | 3 | 16815190 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 10609818 | ||
| Pubmed | Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. | 9.25e-09 | 3 | 74 | 3 | 2023919 | |
| Pubmed | Recent origin of HLA-DRB1 alleles and implications for human evolution. | 9.25e-09 | 3 | 74 | 3 | 9500545 | |
| Pubmed | A novel DRB1*09 allelic sequence in the Jing ethnic minority of China. | 9.25e-09 | 3 | 74 | 3 | 12121280 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 19811438 | ||
| Pubmed | Diversity associated with the second expressed HLA-DRB locus in the human population. | 9.25e-09 | 3 | 74 | 3 | 9162096 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 3099214 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 2471740 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 22531795 | ||
| Pubmed | A novel HLA-DRB1*09 allele, HLA-DRB1*090103*, isolated from the Han population of Guangdong, China. | 9.25e-09 | 3 | 74 | 3 | 15730527 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 20193583 | ||
| Pubmed | Shared class II MHC polymorphisms between humans and chimpanzees. | 9.25e-09 | 3 | 74 | 3 | 2511168 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 8016840 | ||
| Pubmed | Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. | 9.25e-09 | 3 | 74 | 3 | 8775462 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 16441501 | ||
| Pubmed | A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. | 9.25e-09 | 3 | 74 | 3 | 12008082 | |
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 1.86e-08 | 14 | 74 | 4 | 7512597 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 1.86e-08 | 14 | 74 | 4 | 1869305 | |
| Pubmed | 1.86e-08 | 14 | 74 | 4 | 17431094 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 8376762 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 8168144 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 2.53e-08 | 15 | 74 | 4 | 22860026 | |
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 7602119 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 1967269 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 9079699 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 3489470 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 10729169 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 3.37e-08 | 16 | 74 | 4 | 2846691 | |
| Pubmed | 3.37e-08 | 16 | 74 | 4 | 1978941 | ||
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 3.37e-08 | 16 | 74 | 4 | 2543930 | |
| Pubmed | 3.37e-08 | 16 | 74 | 4 | 17959659 | ||
| Pubmed | Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. | 3.37e-08 | 16 | 74 | 4 | 9223324 | |
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 17002906 | ||
| Pubmed | Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype. | 3.69e-08 | 4 | 74 | 3 | 3020127 | |
| Pubmed | HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis. | 3.69e-08 | 4 | 74 | 3 | 15795121 | |
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 14677183 | ||
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 19922436 | ||
| Pubmed | 4.40e-08 | 17 | 74 | 4 | 25240755 | ||
| Pubmed | HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. | 5.65e-08 | 18 | 74 | 4 | 19620308 | |
| Pubmed | 5.65e-08 | 18 | 74 | 4 | 11118314 | ||
| Pubmed | 5.65e-08 | 18 | 74 | 4 | 10661406 | ||
| Pubmed | 8.91e-08 | 20 | 74 | 4 | 7541827 | ||
| Pubmed | 8.91e-08 | 20 | 74 | 4 | 12427289 | ||
| Pubmed | HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. | 9.22e-08 | 5 | 74 | 3 | 17763415 | |
| Pubmed | HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. | 9.22e-08 | 5 | 74 | 3 | 17559577 | |
| Pubmed | 9.22e-08 | 5 | 74 | 3 | 15908298 | ||
| Pubmed | 9.22e-08 | 5 | 74 | 3 | 16916662 | ||
| Pubmed | The role of HLA molecules in susceptibility to chronic rheumatic heart disease. | 9.22e-08 | 5 | 74 | 3 | 16426242 | |
| Pubmed | 1.10e-07 | 21 | 74 | 4 | 21778700 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 2.12e-04 | 71 | 74 | 3 | chr1q22 | |
| Cytoband | 6p21.3 | 7.33e-04 | 250 | 74 | 4 | 6p21.3 | |
| Cytoband | 16q12.1 | 1.39e-03 | 34 | 74 | 2 | 16q12.1 | |
| Cytoband | 4q35.1 | 1.56e-03 | 36 | 74 | 2 | 4q35.1 | |
| GeneFamily | Solute carriers | SLC9A8 SLC16A13 SLC9A3 SLC12A9 RHBG SLC35B4 SLC22A23 SLC17A4 SLC37A2 SLC49A3 SLC34A3 SLC29A2 SLC9C2 SLC2A2 SLC16A8 SLC22A31 | 2.72e-14 | 395 | 55 | 16 | 752 |
| GeneFamily | C1-set domain containing | 7.87e-06 | 42 | 55 | 4 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 9.50e-06 | 44 | 55 | 4 | 588 | |
| GeneFamily | Claudins | 4.52e-05 | 23 | 55 | 3 | 488 | |
| GeneFamily | CD molecules|Tetraspanins | 4.52e-03 | 33 | 55 | 2 | 768 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.30e-02 | 57 | 55 | 2 | 1179 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 3.20e-07 | 21 | 73 | 4 | M41167 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 2.31e-06 | 76 | 73 | 5 | M4551 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 7.79e-07 | 196 | 72 | 6 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.76e-06 | 172 | 72 | 5 | d40a8bd61114b49a5837c836136a13c37c8f7de0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-06 | 172 | 72 | 5 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-06 | 172 | 72 | 5 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-06 | 172 | 72 | 5 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-06 | 172 | 72 | 5 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | facs-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 177 | 72 | 5 | d4cd54c07f1e51b5485270348fb7195d53465027 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 179 | 72 | 5 | 1016af3d61a9276a792629f8b1a28a93038e29c1 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 180 | 72 | 5 | 2b2c656d6620afa32555f14aad94ac56e71e360c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 181 | 72 | 5 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.12e-05 | 181 | 72 | 5 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 182 | 72 | 5 | 942c18a27b22fb33a5200d5717cad972f3ef0576 | |
| ToppCell | 15-Trachea-Immune-Hematopoietic,_B_Cells|Trachea / Age, Tissue, Lineage and Cell class | 1.15e-05 | 182 | 72 | 5 | 1424d990598d37b22fa44df032be97c1cd1363d1 | |
| ToppCell | (1)_B_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.28e-05 | 186 | 72 | 5 | fe0f8e99ca766e004c351835fdbc2dc888dceb62 | |
| ToppCell | (1)_B_CD27pos|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.31e-05 | 187 | 72 | 5 | bb189942123eb03dd6505f1af8771dd7285bb8b9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 188 | 72 | 5 | e32d95f8e86111245d7f4b5fd72d2471fe0f1304 | |
| ToppCell | ICU-SEP-Lymphocyte-B|ICU-SEP / Disease, Lineage and Cell Type | 1.42e-05 | 190 | 72 | 5 | a861506520780932b4630fa285c1e4a77134a505 | |
| ToppCell | B_cell_maturation|World / Lineage and Cell class | 1.42e-05 | 190 | 72 | 5 | 301782283d0c604fb3b428a8ddf1f7cd8e63a90b | |
| ToppCell | wk_20-22-Hematologic-Myeloid-APOE+_Mac1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 191 | 72 | 5 | c204ec71b7755b46a18d3a6aa84d0f407145ce9d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-05 | 192 | 72 | 5 | 4037b4c4fbb40541b8c424c36d3871a57891b8dd | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.53e-05 | 193 | 72 | 5 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-05 | 194 | 72 | 5 | b700381f8337b4c6aa50d09ab5bfcd59f2fb2cf3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 194 | 72 | 5 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 1.57e-05 | 194 | 72 | 5 | cef40ae0bd5c07e73e726100113c46af05548690 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 194 | 72 | 5 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.57e-05 | 194 | 72 | 5 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-05 | 195 | 72 | 5 | 4d7ca21f14730e1b6d0473bc1a11aa626db948f3 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-05 | 195 | 72 | 5 | 8727554ef047ca7f1d4b888a8468f148c64a6918 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-epithelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 195 | 72 | 5 | 9f0ee826d4f0997aee8d63284ed24549bbdf6a28 | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 196 | 72 | 5 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 196 | 72 | 5 | 8862964090f9a679a548103bfbb12e91295aae62 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 197 | 72 | 5 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 197 | 72 | 5 | fd65020089baca78334cecddc96b7a65028c2b7c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-05 | 197 | 72 | 5 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 197 | 72 | 5 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 197 | 72 | 5 | e4b4fa219322b3250b482f8e242f41e8b05485db | |
| ToppCell | Sigmoid-B_cell-Follicular_B_cell|Sigmoid / Region, Cell class and subclass | 1.73e-05 | 198 | 72 | 5 | c3507fb508ace85a31dcff323f9e7ddb9ae6862e | |
| ToppCell | control-B_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.73e-05 | 198 | 72 | 5 | c012b8fbfa8bbc5014217f47acf9177470d8a65a | |
| ToppCell | Sigmoid-(2)_B_cell-(23)_Follicular_B_cell|Sigmoid / shred on region, Cell_type, and subtype | 1.73e-05 | 198 | 72 | 5 | bfb1aa1450d1afb14b875e0cf6796e1a715b4605 | |
| ToppCell | mLN-B_cell|mLN / Region, Cell class and subclass | 1.77e-05 | 199 | 72 | 5 | 99c7d157a1e819ff86c526ffd9b7036ed3514cae | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-05 | 199 | 72 | 5 | 074f21a0075ff6c8e634dc4b12699d371d5f720a | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-B|ICU-SEP / Disease, condition lineage and cell class | 1.77e-05 | 199 | 72 | 5 | 5d4800d0a6340a9db4e895375cf55eeae464709e | |
| ToppCell | mLN-(2)_B_cell|mLN / shred on region, Cell_type, and subtype | 1.77e-05 | 199 | 72 | 5 | 9464c8c72a6b2e14a27b413cc1f5d64550212776 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-05 | 199 | 72 | 5 | e9bdc7e9b841ea5aad2f08e7cc9929d824852718 | |
| ToppCell | MS-IIF-Lymphocyte-B-B_naive|IIF / Disease, condition lineage and cell class | 1.81e-05 | 200 | 72 | 5 | 15f429137b2a3906724118085fcd59750cd767c7 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-B-B_naive|ICU-SEP / Disease, condition lineage and cell class | 1.81e-05 | 200 | 72 | 5 | 1e9d2bd81e39c2368b2e8233e14906ad30ab0511 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 200 | 72 | 5 | 46f9c28b24e39acdf0481a02b6eb86ecdd83c504 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-B_naive|ICU-NoSEP / Disease, condition lineage and cell class | 1.81e-05 | 200 | 72 | 5 | 817c7e2108d54aa9c5f9ad6f59e2c1a84835f8f8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 110 | 72 | 4 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | Severe-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.90e-05 | 117 | 72 | 4 | b5c27f24272216fa9f9107f5d00f3077847bb7ed | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-05 | 134 | 72 | 4 | 0e3f37ef041b751ed45060b5ce39385a2731370b | |
| ToppCell | Mild/Remission-B_intermediate-14|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.06e-05 | 141 | 72 | 4 | 69e32125a0e8f0c8561e5e7a93607f368f09546f | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.13e-04 | 154 | 72 | 4 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.13e-04 | 154 | 72 | 4 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.13e-04 | 154 | 72 | 4 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.13e-04 | 154 | 72 | 4 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 156 | 72 | 4 | 547e2debfc09c07c049a880dded5fda7dd53e156 | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 156 | 72 | 4 | cfd7f56f3155db677684827607e9008e975dbe70 | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 156 | 72 | 4 | 0d79b4172896574b00faf00e87254f68d76f5512 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 156 | 72 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 156 | 72 | 4 | f09150aacb6121f913648ed3918f9cd4f22c61f2 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-04 | 160 | 72 | 4 | 8396afbc7d919ba190863d50aa0ef8b9942a9866 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 162 | 72 | 4 | 448602d5ff8b5be9614c63540a4d0fe6bdaf23b4 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 163 | 72 | 4 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.44e-04 | 164 | 72 | 4 | 92fb94492fc2b683e9d50a9db6f01d23c194b0e4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 167 | 72 | 4 | a813b95c2fafb638b249bc4fa4f708c6f39ad444 | |
| ToppCell | mild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.55e-04 | 167 | 72 | 4 | 0811f7559c2a7151693771e52e14af3978997118 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-04 | 167 | 72 | 4 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 168 | 72 | 4 | 2ec53f91de3bff8a106430a78b81ee6870f0c55e | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 168 | 72 | 4 | 100ab6d36592b61f4db9f8cb90c48afac016d679 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 168 | 72 | 4 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 168 | 72 | 4 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Late_pro-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 170 | 72 | 4 | ad69ebfda452e19eedc453e1d07dacb844d64e47 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 1.69e-04 | 171 | 72 | 4 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.69e-04 | 171 | 72 | 4 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 1.73e-04 | 172 | 72 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-CMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.73e-04 | 172 | 72 | 4 | f18d9f061df3da96e389616abd5edfc269d3adeb | |
| ToppCell | NS-critical-d_0-4-Epithelial-FOXN4+|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-04 | 172 | 72 | 4 | a00bb44d33658cb3a98accd6b60f3ce964c425b4 | |
| ToppCell | Club-club-3|World / Class top | 1.73e-04 | 172 | 72 | 4 | 34fbb82a2ec77dd183cf26b38edeb7e936b707bc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 172 | 72 | 4 | 0bcb960c5ab0d3cbbdf6235b6f28327ea60ba3e3 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-04 | 172 | 72 | 4 | 62ed3b70fa1f6c84ea80ff00f60d2562be292e9d | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 172 | 72 | 4 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 172 | 72 | 4 | 0c6332a806ac75fffae6080f61965555c7f687f4 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.73e-04 | 172 | 72 | 4 | d1ab8f493b70ec995281f9fb0991f1d3aa7b928f | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 1.73e-04 | 172 | 72 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-pDC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 173 | 72 | 4 | b571970e3ba88afc07041c5692ccfd85fc39e796 | |
| ToppCell | control-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.77e-04 | 173 | 72 | 4 | 95af11b7d6c7dcd470943e5bdc56bed7a134e358 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 174 | 72 | 4 | 2a96a4fd7d9ef05213b26103c689cf3a26968713 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 174 | 72 | 4 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 175 | 72 | 4 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 175 | 72 | 4 | 6bb8fc2959583644f16b22e906af91af62a3a633 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 175 | 72 | 4 | d544f24ee33783ed4afb4d7ec079a4484118bb15 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 175 | 72 | 4 | 8902c38067f025b094ca9c28c449c32a66eded1c | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Large_pre-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.89e-04 | 176 | 72 | 4 | 78417a5ac2e45e97e7b4c56c78c25879a1b58f97 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 177 | 72 | 4 | e0035eb725cd412169af1b424119f6422504af93 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-04 | 178 | 72 | 4 | 2e51c1596022b7047994ee13c18375bad19a54a5 | |
| ToppCell | 390C-Lymphocytic-B_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.98e-04 | 178 | 72 | 4 | 02cb514096435a4d8c84f0cc12ae627db319621d | |
| ToppCell | 390C-Lymphocytic-B_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.98e-04 | 178 | 72 | 4 | 9af29e341087ba4dd3ef246cdbae6469ea9de15f | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.98e-04 | 178 | 72 | 4 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| Drug | AC1L8Y60 | 4.15e-07 | 89 | 73 | 6 | CID000410009 | |
| Drug | Palladium | 1.10e-06 | 7 | 73 | 3 | ctd:D010165 | |
| Drug | 3-(2-(3-guanidino-2-methyl-3-oxo-propenyl)-5-methylphenyl)-N-isopropylidene-2-methyl-acrylamide dihydrochloride | 1.01e-05 | 2 | 73 | 2 | ctd:C118956 | |
| Drug | PCMBS | 2.22e-05 | 105 | 73 | 5 | CID000011136 | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 1.00e-08 | 11 | 71 | 4 | DOID:0080822 (is_implicated_in) | |
| Disease | factor VIII measurement | 2.63e-06 | 40 | 71 | 4 | EFO_0004630 | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 5.71e-06 | 2 | 71 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 1.71e-05 | 3 | 71 | 2 | DOID:639 (is_implicated_in) | |
| Disease | systemic scleroderma | 5.38e-05 | 85 | 71 | 4 | EFO_0000717 | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 5.68e-05 | 5 | 71 | 2 | EFO_0801672 | |
| Disease | extranodal nasal NK/T cell lymphoma | 8.51e-05 | 6 | 71 | 2 | MONDO_0019472 | |
| Disease | cancer antigen 15.3 measurement | 1.19e-04 | 7 | 71 | 2 | EFO_0010585 | |
| Disease | interleukin-21 measurement | 1.58e-04 | 8 | 71 | 2 | EFO_0801724 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0007790 | |
| Disease | central nervous system non-hodgkin lymphoma | 2.03e-04 | 9 | 71 | 2 | MONDO_0044887 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0801686 | |
| Disease | CCL19 measurement | 2.54e-04 | 10 | 71 | 2 | EFO_0009415 | |
| Disease | anti-Epstein Barr virus antibody measurement | 3.71e-04 | 12 | 71 | 2 | EFO_0009273 | |
| Disease | Libman-Sacks Disease | 3.75e-04 | 58 | 71 | 3 | C0242380 | |
| Disease | Sjogren syndrome | 4.14e-04 | 60 | 71 | 3 | EFO_0000699 | |
| Disease | Allergic Reaction | 4.78e-04 | 63 | 71 | 3 | C1527304 | |
| Disease | Hypersensitivity | 5.01e-04 | 64 | 71 | 3 | C0020517 | |
| Disease | C-C motif chemokine 19 measurement | 5.10e-04 | 14 | 71 | 2 | EFO_0008047 | |
| Disease | hypothyroidism | 6.18e-04 | 284 | 71 | 5 | EFO_0004705 | |
| Disease | uric acid measurement | 6.60e-04 | 610 | 71 | 7 | EFO_0004761 | |
| Disease | Lupus Erythematosus, Systemic | 6.79e-04 | 71 | 71 | 3 | C0024141 | |
| Disease | anti-anoctamin 2 antibody measurement | 7.58e-04 | 17 | 71 | 2 | EFO_0010150 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 7.58e-04 | 17 | 71 | 2 | EFO_0010559, GO_0035456 | |
| Disease | late-onset myasthenia gravis | 8.52e-04 | 18 | 71 | 2 | EFO_1001490 | |
| Disease | hepatitis B virus infection | 9.51e-04 | 19 | 71 | 2 | EFO_0004197 | |
| Disease | ulcerative colitis, Crohn's disease | 1.05e-03 | 20 | 71 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 1.28e-03 | 22 | 71 | 2 | EFO_0021881 | |
| Disease | Henoch-Schoenlein purpura | 1.28e-03 | 22 | 71 | 2 | EFO_1000965 | |
| Disease | gout | 1.30e-03 | 196 | 71 | 4 | EFO_0004274 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVLLDTGMGLGAAAA | 146 | Q9BQE5 | |
| RILMFLSNGLGFLGL | 81 | A6NM45 | |
| FALGLSGGSLVSMLA | 41 | O95336 | |
| SQLLGGMLGAALAKA | 116 | O94778 | |
| LSALGMLAAGGAGLA | 61 | P08574 | |
| ASHLLVLGSLMGGFT | 156 | P51828 | |
| GLMIAAVSLGFFGSI | 81 | P78369 | |
| LGLLGSLFFLGQALM | 111 | Q96Q80 | |
| LAAFGLSLAGGMELA | 501 | Q8N130 | |
| GGLLASAGMILASFA | 91 | O95907 | |
| MSLFGLLLLTSALAG | 1 | Q9NRA1 | |
| LTLIGGEFFLLGLMA | 106 | Q6IF00 | |
| ISLLLAAGLMHSDAG | 21 | Q6ZSA7 | |
| SKMLSGVGGFVLGLL | 226 | Q30154 | |
| GLGLVFVSSLGSMFL | 251 | Q9H3K2 | |
| AMDGFALGGGLELAL | 131 | Q86YB7 | |
| IGSLLGSVGASLLMV | 81 | Q8IWD5 | |
| MALFGALFLALLAGA | 1 | P55058 | |
| LTLAGAEFFLLGLMS | 96 | P0C7T2 | |
| AAAALALLTGGGEML | 41 | O15173 | |
| SMSLAALLIGGFAGL | 851 | P07202 | |
| ANILSLVGALLMGFS | 131 | P11168 | |
| LGSILSGQSLLMLGS | 506 | Q9P1Y6 | |
| MGGLLLAAFLALVSV | 1 | P62502 | |
| MAGIKALISLSFGGA | 1 | O95214 | |
| ALISLSFGGAIGLMF | 6 | O95214 | |
| LSALLGDLGGQMGLF | 436 | Q96FT7 | |
| ALGFVSLTGLLDMLS | 981 | Q99575 | |
| RILMFLSNGLGFLGL | 81 | Q8N7P3 | |
| GMLLSGLFTSLFGLG | 121 | Q8TED4 | |
| SKMLSGVGGFVLGLL | 226 | P79483 | |
| MGAAGLLGVFLALVA | 1 | P20023 | |
| GTLFGLGLALNSSMY | 266 | P35575 | |
| IALSAGVSLFGMSAL | 76 | Q99643 | |
| SKMLSGVGGFVLGLL | 226 | P01911 | |
| SKMLSGVGGFVLGLL | 226 | P13762 | |
| LVGTLTLAAFLSLGM | 56 | Q5T1A1 | |
| GTMVTGLASLLLLAG | 401 | A6NKX4 | |
| SGSMLGSFIVLLAGG | 206 | Q9Y2C5 | |
| SGSLLKMGSHEGLLF | 191 | Q96RY7 | |
| FVAGLVGALMLAALS | 2651 | Q8TDX9 | |
| LVLAMDLAGAEGGFS | 416 | O75309 | |
| LAISGIFTMGIALLG | 61 | P11049 | |
| AGLAAMVGYALLSGI | 426 | Q13505 | |
| GMLLKSTGSFLEFGL | 756 | Q9Y6R4 | |
| GVSTGAILAFMLGLF | 481 | Q9NP80 | |
| FAFLTIGMGKILLGS | 651 | Q7Z4K8 | |
| LLGIGALTFALLMSA | 161 | Q969S0 | |
| GQGLAGIFAALAMLL | 166 | Q14542 | |
| ATATMIAGSLLLLGF | 21 | O75509 | |
| GLGLVLASAGFGMLT | 571 | A1A5C7 | |
| MAGVGAAALSLLLHL | 1 | Q6ZWJ8 | |
| LGLLAFGALALGLRM | 61 | Q9Y6C5 | |
| IGLLDFLLFGSLMAA | 176 | P48764 | |
| SLGLGLGLSLGMSEA | 21 | Q8NC44 | |
| KMFFGSAALGTLTGL | 266 | Q9Y2E8 | |
| GSGKSSLLAALLGQM | 516 | Q96J65 | |
| SGIFSGLNLGLMALD | 196 | Q6P4Q7 | |
| LGGMIGISASFSALL | 256 | Q6UXD7 | |
| MAAFLSAGLGILAPS | 1 | O75333 | |
| GLALGTTIAVGMLFF | 211 | Q9H6R6 | |
| MGLLNTLSLAFVGGL | 341 | Q9BSA9 | |
| FLMLGSLAAGSGSLY | 606 | Q7RTX1 | |
| GGILAALGMLLASFA | 86 | Q7RTY0 | |
| ALGCSMLGGSLNTAL | 131 | Q96C74 | |
| GLFVTLMFASVGGGL | 396 | Q9H310 | |
| FLISPGAAGGSLLLM | 471 | Q9BXP2 | |
| GAAGGSLLLMGLLAA | 476 | Q9BXP2 | |
| GGARMFGSLLLFALL | 6 | P08949 | |
| LLLIAFSLGSMGFLA | 21 | P52849 | |
| GFLFLTSGMLISVLG | 116 | Q8WVE6 | |
| MLGLALGGLVVSAAS | 121 | Q9H1Z9 | |
| LGMSGTLALAAVGLN | 271 | Q5TAH2 | |
| FGLLFSMLGGLSVGL | 196 | P21731 | |
| SMLGGLSVGLSFLLN | 201 | P21731 | |
| SGLFLGIGLGFMTAV | 496 | Q8IWB9 | |
| MGGALGPALLLTSLF | 1 | Q14957 |